Assessment of Operability in CHD with PAH Krishna Kumar Amrita Institute of Medical Sciences and Research Center Cochin Kerala, India

Congenital Heart Disease 1940 1950 1960 1970 1980 1990 2000 Surgery for PDA Paul Wood: Eisenmenger syndrome, Open heart surgery for common shunts Early Open Heart surgery in Infants Infant open heart surgery widely established in developed countries Infant open heart surgery in selected parts of the developing world 100% Developed world Percentage of infants with large VSD receiving timely surgery Developing world

Pulmonary Vascular Obstructive Disease Definition:  PVR in CHD (Qp) Precludes safe closure PAp high after closure; may further  Timely CHD correction: prevents (but not eliminates) Common in developing world

Estimated proportion of infants with critical CHD undergoing surgery within the first year of life in India Number undergoing surgery in the first year of life Estimated number of infants with critical CHD 2012

Deciding operability of L-R shunts Clinical evaluation Chest X-ray and ECG Measurement of oxygen saturation Echocardiography MRI Cardiac catheterization

Agenda Basic concepts How do we decide on operability of L-R shunts today? What are the indications to perform catheterization? What are the limitations of the tools that we have with us?

What determines the development of pulmonary vascular obstructive disease? Pre vs. post tricuspid Size Associated lesions: pulmonary venous hypertension Lungs and airways obstruction Altitude Syndromes: Tri-21 Anatomy of defect Associated conditions Time Unknown influences * Genetic???

Conceptual framework: Pre-tricuspid shunts: gradual increase in Qp as RV accommodates and enlarges – ASD, PAPVC, TAPVC* Post tricuspid shunts: Direct transmission of pressure head: VSD (systolic), PDA, AP-Window (systolic and diastolic)

Conceptual framework: Pulmonary venous hypertension, associated mitral stenosis, other forms of LV inflow obstruction: May introduce a substantial element of reversibility May protect pulmonary vasculature from the effects of increased pulmonary blood flow???

Conceptual framework: Hypoxia elevates pulmonary vascular resistance Diseases of pulmonary parenchyma Airways (upper and lower) Hypoventilation High altitude

Conceptual framework: Time The likelihood of development of PVOD increases with time The rate of increase in PVR varies depending on a number of influences

Defect vs. PVOD Risk 100% TGA VSD/PDA Unrestrictive VSD or PDA Large Fossa ovalis ASD Truncus SV ASD Likelihood of operability Age Early childhood Infancy Adolescence Adulthood

Risk of development of PVOD: Other (unknown) influences Remarkable individual variability ASD with severe PAH in a child VSD with shunt reversal in an infant Operable AP window in a teenager Operable large VSD in an adult Prediction for an individual patient is sometimes quite challenging

Other (?Genetic) Influences Least Most IPAH?? Risk of PVOD

What principles govern decision on operability? Post tricuspid shunts: Generally operable if there is evidence of a significant shunt in the basal state irrespective of PA pressure Pre-tricuspid shunts: Pulmonary hypertension (anything more than mild) warrants concern especially if basal shunt is not obvious

Deciding operability: Principles Age is an important variable and benefit of doubt must be given to younger patients. E.g. a 1 year old with VSD and severe PAH where basal shunt is not obvious Lung, airway and ventilation issues can elevate PVR and confound assessment Pulmonary venous hypertension can result in reversible elevations in PVR

Congenital Heart Disease (L-R shunts) and Pulmonary Hypertension Maurice Beghetti, and Nazzareno Gali, J. Am. Coll. Cardiol. 2009;53;733-740

Clinical Spectrum of PAH in CHD Operable Clear evidence of a large L-R shunt Typically younger patients Borderline situation: PVR elevated ; operability uncertain. Inoperable: Eisenmenger physiology Shunt reversal Typically older patients

Clearly Operable: Cath not required LV RV LA LV RA RV Clearly Operable: Cath not required

26 year old Blue Single loud S2

Clearly Inoperable: Cath not required RV LV RA LA Clearly Inoperable: Cath not required

Clinical spectrum of post-tricuspid shunts with PAH Operable Failure to thrive,  precordial activity, mid diastolic murmur at apex, Cardiac enlargement, pulmonary blood flow Q in lateral leads on ECG, good LV forces LA/LV enlargement, exclusively L-R flows across the defect Clear clinical /noninvasive evidence of a large left – right shunt Borderline clinical non-invasive data: uncertain operability Cyanosis, quiet precordium, no MDM Normal heart size, peripheral pruning No Q in lateral leads, predominent RV forces No LA LV enlargement, significant R-L flows across the defect Clear evidence of shunt reversal resulting from high PVR. Inoperable

Another Example…… 10 yr old boy Detected to have congenital heart disease in early infancy but did not undergo surgery. Asymptomatic except for an occasional respiratory infection

Evaluation Normal Growth & Development. Pulse: 88/min, BP: 104/70mmHg SPO2: 100% CVS: S1 normal .S2 split normally. A2=P2 Harsh ESM at LUSB. S3+. RS: B/L Clear. No hepatomegaly.

ECG SR @ 75/min. P axis 60deg, QRS axis: 75deg. No e/o atrial enlargement R/S: V1=25/5, V6=35/20. tiny q waves in V6

ECHO

Cath Data (Room Air) Dias(a) Mean O2 % SVC 3 6 2 74.7 RA PA 105 46 75 Chamber Sys(v) Dias(a) Mean O2 % SVC 3 6 2 74.7 RA PA 105 46 75 85 PA wedge 5 PV 98 (a) RV 120 ED= 4 Ao 114 54 77 94.3 PV was not entered. Saturation was assumed Oxygen consumption was assumed

Parameter Condition 1 ( room air) O2 Consumption 156 ml/m2 Qp 6.01 Qs 4.47 Qep 3.5 Qp/Qs 1.34 PVRI 11.82 SVRI 16.78 L-R shunt 2.51

Decision Has cath data helped to make a decision Is he suitable for VSD closure? Do we significantly alter his natural history by intervention? Should we test with pulmonary vasodilators?

FLOW AND RESISTANCE CALCULATIONS Parameter Condition 1 ( room air) Condition 2 (FiO2 100) Condition 3 (NO 40PPM + O2) O2 Consumption 156 152 Qp 6.01 8.66 8.9 Qs 4.47 4.05 3.68 Qep 3.5 Qp/Qs 1.34 2.14 PVRI 11.82 7.5 6.74 SVRI 16.78 19.25 18.2

Our Management Plan The family was counseled Underwent fenestrated VSD closure + PDA ligation

Post op course Uneventful PA pressure 1/3 to ½ systemic Extubated by day 2 Echo at discharge: Fenestration L->R IVG: 60mmHg Discharged on PDE5 inhibitors

Small Fenestration in VSD patch L->R Mild TR. RVSP 65+ RA. Follow Up Echo Small Fenestration in VSD patch L->R Mild TR. RVSP 65+ RA.

CATH Data (On Sildenafil, 1 year later) Chamber Sys(v) Dias(a) Mean O2 % PO2 SVC 79.8 45.9 RA 2 PA 66 30 50 82.7 48.2 PV 99(a) PA wedge 5 LV 120 ED 6 Ao 118 78 98 97.7 93.4 PVRI: 7.96 WU; PVR/SVR ratio: 0.4

Ideally….. Cath Operable Operable Operable Borderline Inoperable

PVR Estimation by Cardiac Catheterization Pulmonary artery mean pressure Pulmonary venous mean pressure Trans-pulmonary gradient PVR = Pulmonary blood flow Oxygen consumption PVO2 content PA O2 Content

Sources of Error / Limitations in Catheterization Data Assumed oxygen saturations Assumed pulmonary vein saturation “Non-physiologic” state Calculated PVRI (basal and post-pulmonary vasodilator) has not been adequately standardized against the gold standard “surgical outcome”

In the Real World…… Operable Inoperable Borderline Operable Inoperable

Cath criteria (Baseline Room Air) Favorable Unfavorable PVRI (Wood U) <6 (Ideally < 4) >8 PVR/SVR ratio <0.3 >0.5 Positive vasodilator: > 20% fall in PVR Lopes et al Pulmonary Circulation 2013

Indication for Cath in ASD Clinical clues may be less obvious than VSD or PDA Echo evidence of elevated PA pressure (RVSP > 50-60 mm Hg: Suggests need for cath Clear evidence of flow reversal (sats < 90%) suggestive of  PVR do not require cardiac cath

Deciding operability of L-R shunts Clinical evaluation Chest X-ray and ECG Measurement of oxygen saturation Echocardiography Resting and post exercise ABG (PO2) Cardiac catheterization ?MRI Viswanathan S, Kumar RK, Assessment of operability in congenital cardiac shunts with increased pulmonary vascular resistance, Cathet Cardiovasc Interv. 2008; 71:665-70

What else can be done in the cath lab? Test occlusion of the defects: ASD PDA Little validation with long term data Immediate reduction of PA pressure may not translate into long term benefits

Illustrative Example 16 year old boy, 9.4 mm duct Nearly systemic PA pressures (Ao 120/60, mean: 90; PA 110/60: mean: 80) LL O2 Saturation: 96% Qp/Qs: 1.15:1 (Qp 3.8; Qs: 3.3) Basal PVRI: 18.75 Wood Units; PVRI/SVRI ratio: 0.66

Illustrative Example Balloon Occlusion PA Ao

Illustrative Example 5 minutes after balloon occlusion Ao: 125/77 (96) PA: 66/18 (41)

Conclusions Comprehensive clinical evaluation supplemented by echocardiography: Allows adequate hemodynamic assessment of for decision making in > 95% of patients with L-R shunts. Cardiac cath and pulmonary vasodilator testing is often done for borderline situations ?uncertain incremental value Some exceptions: Test occlusion of PDA